Evidence map›Paper›PMID 28151044›Full record

ArticleMicrobial drug resistance (Larchmont, N.Y.)2017

Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.

Reza Ghotaslou, Fatemeh Yeganeh Sefidan, Mohammad Taghi Akhi, Mohammad Asgharzadeh, Yalda Mohammadzadeh Asl

Open access · greenAbstract read
In one paragraph

Article in Microbial drug resistance (Larchmont, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2024
    Article
  4. Molecular epidemiology of antibiotic-resistantIranian journal of microbiology · 2023
    Article
  5. The Detection of Fosfomycin-Modifying Enzymes (fos) in Uropathogenic Enterobacterale, Azerbaijan, Iran.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  6. Pathogenesis of thePathogens (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.Frontiers in cellular and infection microbiology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Reza Ghotaslou1 Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences , Tabriz, Iran .
Fatemeh Yeganeh Sefidan1 Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences , Tabriz, Iran .
Mohammad Taghi Akhi2 Department of Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz, Iran .
Mohammad Asgharzadeh3 Department of Laboratory Sciences, Paramedical Faculty and Biotechnology Research Center, Tabriz University of Medical Sciences , Tabriz, Iran .
Yalda Mohammadzadeh Asl2 Department of Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz, Iran .
Tabriz University of Medical Sciences · IRBiotechnology Research Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEnzymatic inactivation is one of the most important mechanisms of resistance to aminoglycosides. The aim of this study was to investigate the prevalence of armA and diversity of the genes encoding aminoglycoside-modifying enzymes (AMEs) and their associations with resistance phenotypes in Enterobacteriaceae isolates.

methodsThree hundred and seven Enterobacteriaceae isolates were collected from five hospitals in northwest Iran. The disk diffusion method for amikacin, gentamicin, tobramycin, kanamycin, and streptomycin, as well as the minimum inhibitory concentration for amikacin, gentamicin, tobramycin, and kanamycin were done for susceptibility testing. Thirteen AME genes and armA methylase were screened using the PCR and sequencing assays.

resultsTwo hundred and twenty (71.7%) of isolates were resistant to aminoglycosides and 155 (70.5%) of them were positive for aminoglycoside resistance genes. The most prevalent AME genes were ant(3″)-Ia and aph(3″)-Ib with the frequency 35.9% and 30.5%, respectively. Also, 21 (9.5%) of resistant isolates were positive for armA methylase gene.

conclusionsThe prevalence of resistance to aminoglycoside is high and AME genes frequently are disseminated in Enterobacteriaceae isolates. There is an association between phenotypic resistance and the presence of some aminoglycoside genes.

Indexed as

Gene Expression Regulation, BacterialGenes, BacterialAmikacinAminoglycosidesAnti-Bacterial AgentsDrug Resistance, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coli ProteinsGentamicinsHospitalsHumansIranKanamycinMethyltransferasesMicrobial Sensitivity TestsAmikacinAminoglycosidesAnti-Bacterial AgentsArmA protein, E coliEscherichia coli ProteinsGentamicinsKanamycinMethyltransferasesStreptomycinTobramycinaminoglycoside-modifying enzymesarmAEnterobacteriaceae

Identifiers

PMID28151044
PMCPMC5665088
OpenAlexW2583754362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.